Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 5;12:803633. doi: 10.3389/fimmu.2021.803633

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Nie, Fang, Chen, Aidina, Qiu, Zhao, Liu, Sun, Li, Zhong, Li and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Chemokine and proinflammatory cytokine concentrations among patients with late-life depression and amnestic mild cognitive impairment and normal controls with standard error of the mean. (A) IL-6 among LLD, aMCI, and control group. (B) CXCL11 among LLD, aMCI, and control group. (C) CCL13 among LLD, aMCI, and control group. (D) CXCL16 among LLD, aMCI, and control group. (E) CCL15 among LLD, aMCI, and control group. aMCI, amnestic mild cognitive impairment; LLD, late-life depression; NC, normal controls; IL-6, interleukin-6; CXCL11, C-X-C chemokine ligand 11; CXCL16, C-X-C chemokine ligand 16; CCL2, C-C chemokine ligand 2; CCL13, C-C chemokine ligand 13; CCL15, C-C chemokine ligand 15. Significance levels are indicated in the top portion of the figure (^* p < 0.05, ^** p < 0.01).